{"public_id":"cl_d42d6ff7c41e548b029bd3e1be43429c","status":"active","superseded_by_public_id":null,"corpus_id":9330608,"text":"siRNA knockdown or pharmacologic inhibition of Bcl-2, Bcl-xL, and XIAP enhances apoptosis of chemoresistant chondrosarcoma cells by up to 5.5 fold at 0.1 μmol and 5.5 fold at 1 μmol doxorubicin.","confidence":0.97,"paper":{"corpus_id":9330608,"title":"siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells","url":"https://sah.borca.ai/papers/9330608"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.97,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_1d350090d4b9de21567e6d73e482bcb1","name":"siRNA knockdown","description":"Gene silencing using small interfering RNA to reduce expression of specific targets.","types":["method"],"url":"https://sah.borca.ai/concepts/co_1d350090d4b9de21567e6d73e482bcb1"},{"public_id":"co_4bd477297d18e56d75eddb73cd6805c5","name":"doxorubicin","description":"An anthracycline chemotherapeutic agent used here to induce and measure drug response.","types":["drug"],"url":"https://sah.borca.ai/concepts/co_4bd477297d18e56d75eddb73cd6805c5"},{"public_id":"co_d2d5bb29fec6590ed8adcbc0bdaa6af9","name":"pharmacologic inhibitors of cell survival proteins","description":"Drugs used to inhibit proteins that promote cell survival and resistance to apoptosis.","types":["treatment approach"],"url":"https://sah.borca.ai/concepts/co_d2d5bb29fec6590ed8adcbc0bdaa6af9"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_d42d6ff7c41e548b029bd3e1be43429c"}